A Novel Quaternary Ammonium N-Propylamiodarone Bromide Provides Long-Lasting Analgesia Against Corneal Pain
The novel quaternary ammonium NPA produced long-lasting analgesia against corneal injury without hampering corneal recovery, suggesting that it is a potential candidate for analgesic medicine targeting corneal pain.
Authors
- Hiroki Hill Kobayashi (ORCID: https://orcid.org/0000-0002-9674-0374)
- Masako Abe (ORCID: https://orcid.org/0000-0002-9675-9817)
- Kenji Kashiwagi (ORCID: https://orcid.org/0000-0001-8506-8503)
- Sohei Hishiyama
- Ayasa Takamino
- Masakazu Kotoda (ORCID: https://orcid.org/0000-0002-9783-2991)
- Yumi Kotoda (ORCID: https://orcid.org/0000-0003-4741-3163)
- Takashi Matsukawa (ORCID: https://orcid.org/0000-0002-5925-9450)
- Jaehoon Shim (ORCID: https://orcid.org/0000-0001-7981-2658)
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- University of Yamanashi (JP)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/dddt.s486031
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science